Concr

Concr launches trial using digital twins for outcome prediction in breast cancer

10 July 2024, London United Kingdom – Concr announces that first patients have been recruited to the VISION trial, an observational clinical study evaluating Concr’s therapeutic response predictive algorithm defining biomarkers of chemotherapy and immunotherapy response in early triple negative breast cancer (TNBC). VISION (NCT06409221) is an observational retrospective study focusing on women who were...
11 Milbrook, Esher, KT10 9EJ, UK

+447888708319